Literature DB >> 6732233

Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.

F Lamothe, F Auger, J M Lacroix.   

Abstract

Clavulanic acid reduced the MICs of amoxicillin, carbencillin , cefamandole, cefotaxime, ceftazidime, ceftizoxime, cephalothin, and penicillin G, but not of cefoxitin or moxalactam, against 77 isolates of the Bacteroides fragilis group, all rapidly beta-lactamase positive by the nitrocefin slide test. It had no effect on the susceptibilities of eight Bacteroides distasonis strains that were slowly beta-lactamase positive (18 h of incubation).

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6732233      PMCID： PMC185612          DOI： 10.1128/AAC.25.5.662

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Clavulanic acid and susceptibility of Bacteroides fragilis to penicillin.

Authors:  R Wise
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

2.  Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.

Authors:  M A Crosby; D W Gump
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.

Authors:  K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

4.  Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.

Authors:  K Dornbusch; B Olsson-Lijequist; C E Nord
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

5.  Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis.

Authors:  J C Pechère; R Guay; J Dubois; R Letarte
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

6.  Cefoxitin inactivation by Bacteroides fragilis.

Authors:  G J Cuchural; F P Tally; N V Jacobus; P K Marsh; J W Mayhew
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

7.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin.

Authors:  T J Marrie; E V Haldane; C A Swantee; E A Kerr
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  In vitro activity of LY127935.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191
View more
  11 in total

1.  National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors:  W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

3.  Activity of cefazolin and two beta-lactamase inhibitors, clavulanic acid and sulbactam, against Bacteroides fragilis.

Authors:  T Fekete; J McGowen; K R Cundy
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 4.  Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

Authors:  S M Finegold; H M Wexler
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

5.  Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.

Authors:  R A Venezia; D M Yocum; E M Robbiano; R M Echols
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

6.  Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Characterization of a beta-lactamase found in Eikenella corrodens.

Authors:  J M Lacroix; C Walker
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase.

Authors:  F Malouin; C Fijalkowski; F Lamothe; J M Lacroix
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 10.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.